Immunogenicity and protective efficacy of ApxIA and ApxIIA DNA vaccine against Actinobacillus pleuropneumoniae lethal challenge in murine model

Taylor, 1999, Actinobacillus pleuropneumoniae, 343 Bosse, 2002, Actinobacillus pleuropneumoniae: pathobiology and pathogenesis of infection, Microbes Infect, 4, 225, 10.1016/S1286-4579(01)01534-9 Frey, 1995, Virulence in Actinobacillus pleuropneumoniae and RTX toxins, Trends Microbiol, 3, 257, 10.1016/S0966-842X(00)88939-8 Dubreuil, 2000, Actinobacillus pleuropneumoniae surface polysaccharides: their role in diagnosis and immunogenicity, Anim Health Res Rev, 1, 73, 10.1017/S1466252300000074 Blackall, 2002, Proposal of a new serovar of Actinobacillus pleuropneumoniae: serovar 15, Vet Microbiol, 84, 47, 10.1016/S0378-1135(01)00428-X Bandara, 2003, Association of Actinobacillus pleuropneumoniae capsular polysaccharide with virulence in pigs, Infect Immun, 71, 3320, 10.1128/IAI.71.6.3320-3328.2003 Shakarji, 2006, Fhua and HgbA, outer membrane proteins of Actinobacillus pleuropneumoniae: their role as virulence determinants, Can J Microbiol, 52, 391, 10.1139/w05-135 Ramjeet, 2005, Truncation of the lipopolysaccharide outer core affects susceptibility to antimicrobial peptides and virulence of Actinobacillus pleuropneumoniae serotype 1, J Biol Chem, 280, 39104, 10.1074/jbc.M502852200 Boekema, 2004, Host cell contact-induced transcription of the type IV fimbria gene cluster of Actinobacillus pleuropneumoniae, Infect Immun, 72, 691, 10.1128/IAI.72.2.691-700.2004 Negrete-Abascal, 2003, Flagella and motility in Actinobacillus pleuropneumoniae, J Bacteriol, 185, 664, 10.1128/JB.185.2.664-668.2003 Garcia-Cuellar, 2000, A 24-kDa cloned zinc metalloprotease from Actinobacillus pleuropneumoniae is common to all serotypes and cleaves actin in vitro, Can J Vet Res, 64, 88 Schaller, 1999, Characterization of apxIVA, a new RTX determinant of Actinobacillus pleuropneumoniae, Microbiology, 145, 2105, 10.1099/13500872-145-8-2105 Boekema, 2004, Both ApxI and ApxII of Actinobacillus pleuropneumoniae serotype 1 are necessary for full virulence, Vet Microbiol, 100, 17, 10.1016/j.vetmic.2003.09.024 Ramjeet, 2008, Actinobacillus pleuropneumoniae vaccines: from bacterins to new insights into vaccination strategies, Anim Health Res Rev, 1 Rioux, 1998, Evaluation of the protective efficacy of Actinobacillus pleuropneumoniae serotype 1 detoxified lipopolysaccharides or O-polysaccharide-protein conjugate in pigs, Res Vet Sci, 65, 165, 10.1016/S0034-5288(98)90170-9 Gerlach, 1993, Molecular characterization of a protective outer membrane lipoprotein (OmlA) from Actinobacillus pleuropneumoniae serotype 1, Infect Immun, 61, 565, 10.1128/IAI.61.2.565-572.1993 Oldfield, 2008, Identification and characterization of novel antigenic vaccine candidates of Actinobacillus pleuropneumoniae, Vaccine, 26, 1942, 10.1016/j.vaccine.2008.02.022 Devenish, 1990, Humoral antibody response and protective immunity in swine following immunization with the 104-kilodalton hemolysin of Actinobacillus pleuropneumoniae, Infect Immun, 58, 3829, 10.1128/IAI.58.12.3829-3832.1990 Bagdasarian, 1999, Immunogenicity of Actinobacillus ApxIA toxin epitopes fused to the E. coli heat-labile enterotoxin B subunit, Vaccine, 17, 441, 10.1016/S0264-410X(98)00216-3 Haesebrouck, 1997, Actinobacillus pleuropneumoniae infections in pigs: the role of virulence factors in pathogenesis and protection, Vet Microbiol, 58, 239, 10.1016/S0378-1135(97)00162-4 Seah, 2002, The N-terminal domain of RTX toxin ApxI of Actinobacillus pleuropneumoniae elicits protective immunity in mice, Infect Immun, 70, 6464, 10.1128/IAI.70.11.6464-6467.2002 Tumamao, 2004, Comparison of the efficacy of a subunit and a live streptomycin-dependent porcine pleuropneumonia vaccine, Aust Vet J, 82, 370, 10.1111/j.1751-0813.2004.tb11108.x Chiers, 1998, Effects of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 9 of pigs vaccinated with inactivated vaccines containing the Apx toxins, Vet Q, 20, 65, 10.1080/01652176.1998.9694841 Willson, 2001, Cloning and characterization of the gene coding for NADPH-sulfite reductase hemoprotein from Actinobacillus pleuropneumoniae and use of the protein product as a vaccine, Can J Vet Res, 65, 206 Rossi-Campos, 1992, Immunization of pigs against Actinobacillus pleuropneumoniae with two recombinant protein preparations, Vaccine, 10, 512, 10.1016/0264-410X(92)90349-O Osorio, 1999, Immunization of dogs and cats with a DNA vaccine against rabies virus, Vaccine, 17, 1109, 10.1016/S0264-410X(98)00328-4 Chen, 2003, Expression and immunogenicity of Mycoplasma hyopneumoniae heat shock protein antigen P42 by DNA vaccination, Infect Immun, 71, 1155, 10.1128/IAI.71.3.1155-1160.2003 Rogers, 1999, Construction and immunogenicity of DNA vaccine plasmids encoding four Plasmodium vivax candidate vaccine antigens, Vaccine, 17, 3136, 10.1016/S0264-410X(99)00146-2 Saldarriaga, 2006, Immunogenicity of a multicomponent DNA vaccine against visceral leishmaniasis in dogs, Vaccine, 24, 1928, 10.1016/j.vaccine.2005.10.052 Hung, 2007, A DNA vaccine encoding a single-chain trimer of HLA-A2 linked to human mesothelin peptide generates anti-tumor effects against human mesothelin-expressing tumors, Vaccine, 25, 127, 10.1016/j.vaccine.2006.06.087 Gurunathan, 2000, DNA vaccines: immunology, application, and optimization, Annu Rev Immunol, 18, 927, 10.1146/annurev.immunol.18.1.927 Liao, 2003, Oral immunization using formalin-inactivated Actinobacillus pleuropneumoniae antigens entrapped in microspheres with aqueous dispersion polymers prepared using a co-spray drying process, Prev Vet Med, 61, 1, 10.1016/S0167-5877(02)00195-2 Yang, 2005, Epitope mapping of Mycoplasma hyopneumoniae using phage displayed peptide libraries and the immune responses of the selected phagotopes, J Immunol Methods, 304, 15, 10.1016/j.jim.2005.05.009 Jolie, 1995, Cross-protection experiments in pigs vaccinated with Actinobacillus pleuropneumoniae subtypes 1A and 1B, Vet Microbiol, 45, 383, 10.1016/0378-1135(94)00145-M Haga, 1997, Protective efficacy of an affinity-purified hemolysin vaccine against experimental swine pleuropneumonia, J Vet Med Sci, 59, 115, 10.1292/jvms.59.115 Salonius, 2007, The road to licensure of a DNA vaccine, Curr Opin Investig Drugs, 8, 635 Shin, 2007, Enhancement of protective immune responses by oral vaccination with Saccharomyces cerevisiae expressing recombinant Actinobacillus pleuropneumoniae ApxIA or ApxIIA in mice, J Vet Sci, 8, 383, 10.4142/jvs.2007.8.4.383 Park, 2006, Enhanced immune response with foot and mouth disease virus VP1 and interleukin-1 fusion genes, J Vet Sci, 7, 257, 10.4142/jvs.2006.7.3.257 Beaudet, 1994, Protection of mice and swine against infection with Actinobacillus pleuropneumoniae by vaccination, Vet Microbiol, 39, 71, 10.1016/0378-1135(94)90087-6